IQVIA MedTech(@IQVIA_MedTech) 's Twitter Profile Photo

In our latest whitepaper, IQVIA’s Dr. Pravindra Awasthi and Megha Maheshwari consider the delicate balance between AI-based innovations and ethical considerations. Download now to read their insights in full.
bit.ly/44mncOZ

In our latest whitepaper, IQVIA’s Dr. Pravindra Awasthi and Megha Maheshwari consider the delicate balance between AI-based innovations and ethical considerations. Download now to read their insights in full.
bit.ly/44mncOZ
#MedTech #AI
account_circle
Ryan sikorski(@Ryansikorski10) 's Twitter Profile Photo

How does that work when the intelligence community has front companies like IQVIA that collects data from pharmacies to pinpoint areas that need doctors to sell more opioids to further its drug epidemic in rural White communities? IQVIA is one of many government intelligence…

account_circle
CNBC-TV18(@CNBCTV18Live) 's Twitter Profile Photo

| ’s marketing partner, Amneal Pharma launches Pemetrexed injection 10 mg/mL in the US market

Pemetrexed Injection is used as a drug, in the treatment of non-small cell lung cancer in combination with other chemotherapy agents

According to IQVIA®, U.S.…

#JustIN | #ShilpaMedicare’s marketing partner, Amneal Pharma launches Pemetrexed injection 10 mg/mL in the US market

Pemetrexed Injection is used as a drug, in the treatment of non-small cell lung cancer in combination with other chemotherapy agents

According to IQVIA®, U.S.…
account_circle
Exencial Research Partners(@exencial_RP) 's Twitter Profile Photo

As per IQVIA, DRRD’s organic domestic sales reported a 7.6% CAGR, over FY2017-24E.

IQVIA domestic sales CAGR, March fiscal year-ends,
2017-24E (%).

As per IQVIA, DRRD’s organic domestic sales reported a 7.6% CAGR, over FY2017-24E.

IQVIA domestic sales CAGR, March fiscal year-ends,
2017-24E (%).

#CAGR #Sales #Pharmaceuticals #Finance
account_circle
Sekhar(@LearningEleven) 's Twitter Profile Photo

Antique on India Pharma: FY25 should be good!

📌As per IQVIA IMS, the Indian Pharmaceutical Market (IPM) reported an 8% YoY growth for FY24, primarily led by price increases.

📌Overall, for FY25, we expect IPM to grow at a healthy rate of ~8%–10%, driven by volume recovery, a…

account_circle
(RED)(@RED) 's Twitter Profile Photo

As global demand for medicine increases, there’s still much work to be done to expand access and ensure medicines reach the patients who will benefit most from them. IQVIA Institute

Learn more: bit.ly/3Jim598

As global demand for medicine increases, there’s still much work to be done to expand access and ensure medicines reach the patients who will benefit most from them. #STATurday #IQVIAInstitute  @IQVIA_Institute 
 
Learn more: bit.ly/3Jim598
account_circle
@IQVIACompliance(@iqviacompliance) 's Twitter Profile Photo

A proactive digital approach is now a crucial differentiator as legacy systems hinder progress. In this article, IQVIA’s Mike King explores accelerating commercial performance with while ensuring safe patient care. Read now.
bit.ly/3Q2d6wH

A proactive digital #qualitymanagement approach is now a crucial differentiator as legacy systems hinder progress. In this article, IQVIA’s Mike King explores accelerating commercial performance with #eQMS while ensuring safe patient care. Read now.
bit.ly/3Q2d6wH
account_circle
Stock Analysis Compilation(@StockCompil) 's Twitter Profile Photo

Oakmark Funds on IQVIA $IQV:

'We also appreciate CEO Ari Bousbib’s strong track record on operations and capital allocation, and we are impressed by his large equity holdings in the company'

(Extract from their Q1 letter)

Oakmark Funds on IQVIA $IQV:  

'We also appreciate CEO Ari Bousbib’s strong track record on operations and capital allocation, and we are impressed by his large equity holdings in the company'  

(Extract from their Q1 letter)
account_circle
@IQVIACompliance(@iqviacompliance) 's Twitter Profile Photo

Calling all mid-size and large pharma companies! Join IQVIA’s experts on May 7th for a webinar on global expansion. Explore post-approval lifecycle management and local intricacies. Reserve your space: bit.ly/3JiW21F

Calling all mid-size and large pharma companies! Join IQVIA’s experts on May 7th for a webinar on global expansion. Explore post-approval #regulatory lifecycle management and local #pharmacovigilance intricacies. Reserve your space: bit.ly/3JiW21F
#drugsafety
account_circle
IQVIA Japan(@IQVIA_Japan) 's Twitter Profile Photo

【5/9(木)18時開催】
CRA向けキャリアディベロップメントWebinar

全編カメラオフ&ご質問はチャットからOK!
お気軽にご参加ください

bit.ly/445EBLu

【5/9(木)18時開催】
CRA向けキャリアディベロップメントWebinar

全編カメラオフ&ご質問はチャットからOK!
お気軽にご参加ください

bit.ly/445EBLu

#CRA #IQVIAwebinar
account_circle
MarketsandMarkets™(@marketsmarkets) 's Twitter Profile Photo

🎙️We're soon coming with a new with Guy Rachmuth, VP—Corporate Strategy, Enterprise, IQVIA, & Yamini Jain, VP—Healthcare, MarketsandMarkets™. Join us to unravel various transformations in . Stay tuned for more!

account_circle
Global Market Insights(@IQVIA_GMI) 's Twitter Profile Photo

industry's &A focus in Q4 2023 was primarily on oncology, but we expect neurology and cardiometabolic indications to gain traction in 2024. Explore the insights into these therapeutic area trends bit.ly/49JB8DF

#biopharma industry's #M&A focus in Q4 2023 was primarily on oncology, but we expect neurology and cardiometabolic indications to gain traction in 2024. Explore the insights into these therapeutic area trends #PharmaDeals #StrategicAcquisitions bit.ly/49JB8DF
account_circle
Global Market Insights(@IQVIA_GMI) 's Twitter Profile Photo

IQVIA Institute’s latest report finds that health care systems’ infrastructure and the complexities of the patient journey pose significant barriers to the future success and sustainability of these treatments. To learn more: bit.ly/4cXkxis

IQVIA Institute’s latest report finds that health care systems’ infrastructure and the complexities of the patient journey pose significant barriers to the future success and sustainability of these treatments. To learn more:  bit.ly/4cXkxis  #PharmaDeals
account_circle
IQVIA UK(@IQVIA_UK) 's Twitter Profile Photo

Yesterday at the HFMA costing conference, had the pleasure of connecting with attendees and discussing how our collaborative efforts can enhance healthcare systems and ultimately lead to better care, outcomes, and research for patients!

Yesterday at the HFMA costing conference, #IQVIA had the pleasure of connecting with attendees and discussing how our collaborative efforts can enhance healthcare systems and ultimately lead to better care, outcomes, and research for patients!
account_circle